An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of $7.00 ...
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of $7.00 ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...
Profound Medical (Nasdaq:PROF) announced today that it sold shares of common stock worth proceeds of up to $40 million. Toronto-based Profound sold more than 5.1 million shares of common stock at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback